ANN SCHMIT: Open Payments
NPI 1003561218 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 7 payments from 6 companies in 2025. Trend: 2023 $259 · 2024 $677 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $189 |
| Edwards Lifesciences Corporation | 1 | $134 |
| Alnylam Pharmaceuticals Inc. | 1 | $133 |
| Amgen Inc. | 1 | $86 |
| PFIZER INC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, SAPIEN 3 Ultra RESILIA, AMVUTTRA, ELIQUIS.
Industry payments across IN — which companies pay providers there.
